Werum PAS-X MES will be implemented in a greenfield cell and gene site in Beijing by Körber and Immunotech Biopharm. This is a significant step in Immunotech's digital transformation to intelligent manufacturing.
Immunotech, the local leader in cell and gene therapy in China, sees digitization and intelligent manufacturing as a key strategy. Immunotech will create a new smart factory in Beijing by implementing Körber's Manufacturing Execution System (MES) Werum PAS-X, which will ensure safety and efficiency while allowing connectivity and data transfer throughout the manufacturing process. As a result, the company will be able to expedite the strategic process of digitalization and intelligence, as well as providing the market with more high-quality products and services.
“We are very pleased to reach a comprehensive cooperation with Körber,” says Dr. Wang Yu, Chief Executive Officer (CEO) of Immunotech Biopharm Ltd. “As the market leader, Werum PAS-X MES has unique advantages, which offers us innovative concepts and industry best practices. PAS-X combines software, content and services, and ensures fast deployment. I am looking forward to our joint cooperation, laying a solid foundation for Immunotech to accelerate product commercialization as well as to provide strong technical support to achieve our ultimate goal of curing patients.”
Jerry Zheng, General Manager China Hub of Körber Business Area Pharma, adds: “Against the backdrop of Industry 4.0, the strategic plan ‘Made in China 2025’ and the integration of digitization and intelligence in various industries across China, leveraging technology to assist the pharmaceutical industry is the trend of the future. Our PAS-X software solution has always been focusing on the factory and supply chain, while taking into account the specific requirements of the regulatory agencies and the industry itself. MES is an important entry point and breakthrough to drive intelligent manufacturing, and it is an important vehicle for the digital transformation of pharmaceutical companies.”
